OXFORD NANOPORE TECHNOLOGIES PLC Financials Oxford Nanopore Technologies plc
Equities
ONT
GB00BP6S8Z30
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.8 GBX | +3.76% |
|
+5.54% | -49.66% |
| Jul. 04 | HSBC raises Bunzl to 'buy'; RBC likes Ibstock | AN |
| Jun. 12 | Oxford Nanopore Technologies plc Announces Termination of Wendy Mira Becker as Director | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,726 | 2,034 | 1,788 | 915.9 | - | - |
| Enterprise Value (EV) 1 | 5,263 | 1,712 | 1,560 | 606.7 | 716.6 | 798.7 |
| P/E ratio | -30.3 x | -22.4 x | -11 x | -5.25 x | -6.27 x | -7.45 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 42.8 x | 10.2 x | 10.5 x | 4.87 x | 3.79 x | 2.97 x |
| EV / Revenue | 39.4 x | 8.62 x | 9.19 x | 3.23 x | 2.96 x | 2.59 x |
| EV / EBITDA | -91.2 x | -21.8 x | -14.9 x | -5.45 x | -8.46 x | -14.9 x |
| EV / FCF | -69.8 x | -18.7 x | -9.59 x | -4.72 x | -6.49 x | -8.92 x |
| FCF Yield | -1.43% | -5.35% | -10.4% | -21.2% | -15.4% | -11.2% |
| Price to Book | 8.15 x | 2.93 x | 2.7 x | 1.82 x | 2.54 x | 3.48 x |
| Nbr of stocks (in thousands) | 820,404 | 825,255 | 858,887 | 873,921 | - | - |
| Reference price 2 | 6.980 | 2.465 | 2.082 | 1.048 | 1.048 | 1.048 |
| Announcement Date | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 133.7 | 198.6 | 169.7 | 188 | 241.7 | 308.7 |
| EBITDA 1 | - | -57.7 | -78.63 | -104.9 | -111.3 | -84.72 | -53.53 |
| EBIT 1 | - | -82.9 | -110.5 | -146.6 | -159.2 | -135 | -108.2 |
| Operating Margin | - | -62.02% | -55.64% | -86.38% | -84.69% | -55.86% | -35.06% |
| Earnings before Tax (EBT) 1 | - | -166 | -83.41 | -149.8 | -150.9 | -130 | -113.3 |
| Net income 1 | -61.24 | -167.6 | -91.02 | -154.5 | -158.1 | -140.7 | -112 |
| Net margin | - | -125.4% | -45.83% | -91.06% | -84.09% | -58.2% | -36.28% |
| EPS 2 | -1.990 | -0.2300 | -0.1100 | -0.1900 | -0.1998 | -0.1672 | -0.1406 |
| Free Cash Flow 1 | - | -75.36 | -91.62 | -162.7 | -128.7 | -110.4 | -89.55 |
| FCF margin | - | -56.38% | -46.13% | -95.91% | -68.43% | -45.65% | -29.01% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 8/2/21 | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 74.71 | 122.3 | 76.26 | 86 | 83.67 | 90 | 104 | 114 | 132 | 145 |
| EBITDA 1 | -25.86 | -34.61 | -44.02 | -39.37 | -65.56 | -41 | -66 | -33 | -61 | -18 |
| EBIT 1 | -39.33 | -22.96 | -59.76 | -74.78 | -87.32 | -61 | -82 | -59 | -81 | -50 |
| Operating Margin | -52.64% | -18.77% | -78.37% | -86.96% | -104.37% | -67.78% | -78.85% | -51.75% | -61.36% | -34.48% |
| Earnings before Tax (EBT) 1 | -121.6 | -27.63 | -55.78 | -66.56 | -83.21 | -61 | -81 | -58 | -81 | -50 |
| Net income 1 | -122.8 | -30.18 | -60.85 | -70.1 | -13.11 | -64 | -84 | -61 | -84 | -53 |
| Net margin | -164.35% | -24.66% | -79.8% | -81.51% | -15.67% | -71.11% | -80.77% | -53.51% | -63.64% | -36.55% |
| EPS 2 | -0.1100 | -0.0400 | -0.0700 | -0.0800 | -0.1100 | -0.0800 | -0.1000 | -0.0700 | -0.1000 | -0.0600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/22/22 | 9/13/22 | 3/21/23 | 9/6/23 | 3/6/24 | - | - | - | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 463 | 323 | 228 | 309 | 199 | 117 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -75.4 | -91.6 | -163 | -129 | -110 | -89.6 |
| ROE (net income / shareholders' equity) | - | -19% | -13% | -23.1% | -29% | -34.6% | -38.8% |
| ROA (Net income/ Total Assets) | - | -15.1% | -10.9% | -19.3% | -22.9% | -25.6% | -25.6% |
| Assets 1 | - | 1,111 | 832.9 | 800.5 | 691.6 | 548.8 | 437.7 |
| Book Value Per Share 2 | - | 0.8600 | 0.8400 | 0.7700 | 0.5700 | 0.4100 | 0.3000 |
| Cash Flow per Share 2 | - | -0.0700 | -0.0600 | -0.1600 | -0.1200 | -0.0800 | -0.0600 |
| Capex 1 | - | 21.5 | 42.2 | 25.4 | 33 | 34.6 | 32.6 |
| Capex / Sales | - | 16.11% | 21.27% | 14.99% | 17.57% | 14.31% | 10.56% |
| Announcement Date | 8/2/21 | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
1.048
GBP
Average target price
1.819
GBP
Spread / Average Target
+73.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -49.66% | 1.13B | |
| +1.15% | 203B | |
| +4.69% | 178B | |
| +31.83% | 157B | |
| +33.39% | 112B | |
| +2.21% | 64.58B | |
| +22.99% | 56.33B | |
| -4.03% | 46.75B | |
| -8.60% | 36.59B | |
| +2.35% | 35.09B |
- Stock Market
- Equities
- ONT Stock
- Financials Oxford Nanopore Technologies plc
